CLINICAL_TRIALS
trial_result
· 2022-12-28
Clinical Trial Update: OLAParib COmbinations [Phase 2]
Summary
Phase 2 clinical trial update for OLAparib combinations in cancer has terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Joseph Paul Eder | Conditions: Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-12-28